MEREO BIOPHARMA GROUP PL-ADR (MREO)

US5894921072 - ADR

3.27  +0.1 (+3.15%)

After market: 3.17 -0.1 (-3.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
36.46M8.091M
EBITDA
YoY % growth
-35.97M
5.19%		-20.3M
43.56%		-42.84M
-111.03%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-37.57M
4.93%		-20.94M
44.26%		-43.57M
-108.07%		-28.662M
34.22%
Operating Margin
N/A-57.43%N/A-354.25%
EPS
YoY % growth
N/AN/AN/A-0.04

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q2 / 24 Q4 / 24
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 5.56%
RevenueN/A N/A 0% 0%